MAnnitol for Blood Pressure Stability in HemoDialysis (MAP-HD)

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 6, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Hemodialysis ComplicationHemodynamic Instability

Interventions

DRUG

Mannitol

Hypertonic mannitol infusion

DRUG

0.9% saline

Normal saline 'placebo' arm

Trial Locations (1)

RECRUITING

Brigham and Women's, Boston

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER